Skip to main content
. 2022 Jun 30;5(6):e2219535. doi: 10.1001/jamanetworkopen.2022.19535

Figure 2. Receipt of Immunotherapy Among Patients With Non–Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma (RCC).

Figure 2.

Data were derived from multivariable logistic regression models. Displayed covariates were selected from a larger multivariable logistic regression model that also included sex and tumor histological characteristics (additional details are available in eTables 4 and 5 in the Supplement). OR indicates odds ratio.

aOdds ratio estimates were generated based on 10 imputations with this sample.

bNon-Hispanic serves as the reference for Hispanic and White as the reference for Black and other. Although they are presented together, in the National Cancer Database12 and in our models, race and ethnicity were treated as separate variables. See Methods for details on other races and ethnicities.